Xencor Inc (XNCR) stock
XNCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30194% above fair value
$34.39−0.11 (-0.32%)
Close on Nov 18, 2026Market cap $2.56BP/E –Yield –
Xencor market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Xencor's market cap was $2.97B on Nov 11, 2026, against $1.24B a year earlier. Over the last 5 years it ranged from $559.13M to $2.97B, with a median of $1.33B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.97B | +172.0% |
| 2025 | Dec 31, 2025 | $1.09B | -32.1% |
| 2024 | Dec 31, 2024 | $1.61B | +24.8% |
| 2023 | Dec 29, 2023 | $1.29B | -17.3% |
| 2022 | Dec 30, 2022 | $1.56B | -33.6% |
| 2021 | Dec 31, 2021 | $2.35B | -6.3% |
| 2020 | Dec 31, 2020 | $2.50B | +28.3% |
| 2019 | Dec 31, 2019 | $1.95B | -4.0% |
| 2018 | Dec 31, 2018 | $2.03B | +97.5% |
| 2017 | Dec 29, 2017 | $1.03B | -4.9% |
| 2016 | Dec 30, 2016 | $1.08B | +83.0% |
| 2015 | Dec 31, 2015 | $591.77M | +17.6% |
| 2014 | Dec 31, 2014 | $503.04M | +76020.9% |
| 2013 | Dec 31, 2013 | $660.84K | – |
See a number that looks wrong?